InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: BioNewton post# 38617

Thursday, 07/16/2015 12:23:44 PM

Thursday, July 16, 2015 12:23:44 PM

Post# of 144814
Yes, it is very telling that liver cancer is mentioned in today's PR. And note, it is the doctor who sees the additional uses for CiaB technology.

"Dr. Hidalgo’s interest in using our Cell-in-a-Box® technology to develop treatments for other solid tumors, like liver cancer, means that his addition to our Scientific Advisory Board could well pave the way towards a fruitful future for PharmaCyte Biotech.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News